Jasprit Bumrah Injury Update: Team India’s ace pacer Jasprit Bumrah’s return to competitive cricket might take a while as he’s still not fit enough to play such big events. According to the sources, ...
Pakistan pacer Mohammad Amir is hoping that he can play in the IPL in 2026 after he obtains a British passport. Amir also said that his favourite team in the IPL is Royal Challengers Bengaluru, where ...
New Zealand's front-line pacer, Matt Henry, faces a challenge to be fit for the Champions Trophy final due to a shoulder injury sustained during the semi-final against South Africa in Lahore. Henry, ...
The star pacer, who had been recovering from a back injury, recently resumed bowling in the nets. In a video shared on his Instagram, Bumrah stunned fans with a deadly yorker that shattered the ...
SAN FRANCISCO - Nektar Therapeutics (NASDAQ:NKTR), currently trading at $0.87 with a market capitalization of $162.5 million, announced today that it has achieved target enrollment for its Phase ...
Nekter Juice Bar is expected to open in north McKinney. (Courtesy Nekter Juice Bar) A second Nekter Juice Bar franchise is expected to open in McKinney. Construction on the store started in ...
Last month, we reported that Native Instruments was planning to expand its software ecosystem by teaming up with a handful of competitors to integrate its NKS protocol with their products. Today, the ...
At his pre-match press conference before the big game against India, Bangladesh cricket team captain Najmul Hossain Shanto heaped praise on his pace attack. Then he spoke about 22-year-old Nahid Rana, ...
SAN FRANCISCO, Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that it will host a virtual investor and analyst event with Type 1 Diabetes (T1D) Experts on Monday, ...
Dr. Megan Levings, Professor, Department of Surgery and School of Biomedical Engineering at The University Of British Columbia; and, Dr. Daniel Moore, Associate Professor of Pediatrics and ...
You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...
SAN FRANCISCO and NEW YORK, Feb. 24, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) and TrialNet, an international clinical trial network at the forefront of diabetes research, today ...